We are live on ! Find out more
FRA

Front Row Advisors Portfolio holdings

AUM $296M
1-Year Est. Return 34.73%
This Fund
S&P 500
This Quarter Est. Return
+3.24%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
–
AUM
$137M
AUM Growth
+$8.91M
Cap. Flow
+$5.42M
Cap. Flow %
3.95%
Top 10 Hldgs %
25.75%
Holding
1,127
New
41
Increased
160
Reduced
183
Closed
74

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$2.38M
2
BEAT
BioTelemetry, Inc.
BEAT
+$1.32M
3
RPM icon
RPM International
RPM
+$798K
4
DIS icon
Walt Disney
DIS
+$758K
5
COST icon
Costco
COST
+$641K

Top Sells

Rank Stock Value
1
IRBT
iRobot
IRBT
+$1.7M
2
MDSO
Medidata Solutions, Inc.
MDSO
+$958K
3
MSFT icon
Microsoft
MSFT
+$206K
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$129K
5
AAPL icon
Apple
AAPL
+$111K

Sector Composition

Rank Sector Weight
1 Technology 27.32%
2 Healthcare 15.28%
3 Financials 10.67%
4 Consumer Staples 7.75%
5 Consumer Discretionary 5.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TM icon
826
Toyota
TM
$211B
$2K ﹤0.01%
15
-10
-40% -$1.22K
TOL icon
827
Toll Brothers
TOL
$14.1B
$2K ﹤0.01%
55
+22
+67% +$821
TPH
828
DELISTED
Tri Pointe Homes
TPH
$2K ﹤0.01%
173
– –
TTWO icon
829
Take-Two Interactive
TTWO
$43.1B
$2K ﹤0.01%
15
– –
TX icon
830
Ternium
TX
$9.27B
$2K ﹤0.01%
77
+47
+157% +$1.18K
UMC icon
831
United Microelectronic
UMC
$48.9B
$2K ﹤0.01%
1,081
+54
+5% +$110
URI icon
832
United Rentals
URI
$70.9B
$2K ﹤0.01%
15
– –
USPH icon
833
US Physical Therapy
USPH
$1.14B
$2K ﹤0.01%
14
– –
VC icon
834
Visteon
VC
$2.82B
$2K ﹤0.01%
30
– –
VEEV icon
835
Veeva Systems
VEEV
$30B
$2K ﹤0.01%
10
– –
VONV icon
836
Vanguard Russell 1000 Value ETF
VONV
$20.4B
$2K ﹤0.01%
44
– –
VOOG icon
837
Vanguard S&P 500 Growth ETF
VOOG
$25.6B
$2K ﹤0.01%
60
– –
VRTX icon
838
Vertex Pharmaceuticals
VRTX
$122B
$2K ﹤0.01%
9
– –
VWOB icon
839
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.15B
$2K ﹤0.01%
+25
New +$1.96K
WDC icon
840
Western Digital
WDC
$183B
$2K ﹤0.01%
52
-26
-33% -$891
WF icon
841
Woori Financial
WF
$15.9B
$2K ﹤0.01%
52
+2
+4% +$72
WSM icon
842
Williams-Sonoma
WSM
$26.6B
$2K ﹤0.01%
68
– –
WTS icon
843
Watts Water Technologies
WTS
$11.5B
$2K ﹤0.01%
24
– –
XPH icon
844
State Street SPDR S&P Pharmaceuticals ETF
XPH
$471M
$2K ﹤0.01%
44
– –
ZM icon
845
Zoom
ZM
$25.5B
$2K ﹤0.01%
+25
New +$2.06K
EGRX
846
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$2K ﹤0.01%
40
– –
PRFT
847
DELISTED
Perficient Inc
PRFT
$2K ﹤0.01%
45
– –
DOOR
848
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$2K ﹤0.01%
32
– –
CPE
849
DELISTED
Callon Petroleum Company
CPE
$2K ﹤0.01%
29
– –
NATI
850
DELISTED
National Instruments Corp
NATI
$2K ﹤0.01%
50
– –
32 33
34
35 36

Similar funds

SM
Skaana Management Brooklyn, New York $296M AUM 65.1% 1-Year Est. Return
RHP
Royal Harbor Partners Houston, Texas $295M AUM 14.06% 1-Year Est. Return
MSWM
Master's Wealth Management Lancaster, Pennsylvania $295M AUM 15.96% 1-Year Est. Return
RLIM
Red Lighthouse Investment Management New York $296M AUM 22.04% 1-Year Est. Return
JCM
Jacobsen Capital Management Salt Lake City, Utah $296M AUM 24.47% 1-Year Est. Return
CA
Claar Advisors New York $295M AUM 12.26% 1-Year Est. Return
NRC
New Republic Capital Charlotte, North Carolina $297M AUM 24.5% 1-Year Est. Return
MFC
Morris Financial Concepts Mount Pleasant, South Carolina $295M AUM 17.25% 1-Year Est. Return

Front Row Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Front Row Advisors held 1,127 positions worth $137M, up 6.9% from $128M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Front Row Advisors deployed $5.42M of net new capital in Q2 2019, opening 41 new positions and adding to 160 existing holdings. Its largest new stake was BioTelemetry, Inc.: 25,089 shares worth $1.21M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Microsoft, an estimated $206K trimmed.

  • Front Row Advisors's largest Q2 2019 buy was BioTelemetry, Inc.: 25,089 shares worth $1.21M.
  • Front Row Advisors added most to Medtronic in Q2 2019, an estimated $2.38M increase.
  • Front Row Advisors's biggest Q2 2019 reduction was Microsoft, cutting an estimated $206K.
  • Front Row Advisors fully exited iRobot in Q2 2019, selling an estimated $1.7M.
  • Front Row Advisors's ten largest holdings make up 26% of its $137M portfolio in Q2 2019.
  • Front Row Advisors opened 41 new positions and closed 74 in Q2 2019.
  • Front Row Advisors's portfolio value rose 6.9% quarter-over-quarter to $137M.

Based on Front Row Advisors's 13F filing for Q2 2019, filed 27 Aug 2019.